J Gynecol Oncol.  2008 Jun;19(2):99-107. 10.3802/jgo.2008.19.2.99.

Fertility preservation for women with malignancies: current developments of cryopreservation

Affiliations
  • 1Health Promotion Center, Seoul National University Bundang Hospital, Seongnam, Korea. suhcs@snu.ac.kr
  • 2Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 3Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

The preservation of fertility in female cancer survivors has become an important health issue. The different cryopreservation options available for fertility preservation are embryo, oocyte, and ovarian tissue cryopreservation. Oocyte cryopreservation is available for women without partners, but there is a limited experience with this technique and the pregnancy rate is still low. In spite of recent reports of successful birth after autotransplantation of cryopreserved-thawed human ovarian cortical tissues, clinical experience is also limited and this technique remains still experimental. Whole ovary cryopreservation itself poses several challenges. Further researches for establishing optimal cryopreservation and thawing protocols and increasing post-thawing survival, pregnancy, and delivery rates are necessary. In this article, the strategies for fertility preservation in cancer survivors are discussed. The different options and their results are discussed, as well as their indications, efficacy and ethical issues.

Keyword

Fertility preservation; Embryo cryopreservation; Oocyte cryopreservation; Ovarian tissue cryopreservation; Ovarian transplantation

MeSH Terms

Cryopreservation
Embryonic Structures
Female
Fertility
Fertility Preservation
Humans
Oocytes
Ovary
Parturition
Pregnancy
Pregnancy Rate
Survivors

Figure

  • Fig. 1 Algorithm summarizing strategies for the preservation of fertility in female cancer patient.


Reference

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006. 56:106–130.
2. Korea Central Cancer Registry, Ministry of Health and Welfare Republic of Korea. 2002 Annual report of the Korea Central Cancer Registry. 2003. Seoul: Ministry of Health and Welfare.
3. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin. 1990. 40:355–367.
4. Apperley JF, Reddy N. Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev. 1995. 9:93–116.
5. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: Final data for 2002. Natl Vital Stat Rep. 2003. 52:1–113.
6. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003. 88:5307–5314.
7. Porcu E, Fabbri R, Seracchioli R, Ciotti PM, Magrini O, Flamigni C. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril. 1997. 68:724–726.
8. Bahadur G, Steele SJ. Ovarian tissue cryopreservation for patients. Hum Reprod. 1996. 11:2215–2216.
9. Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004. 363:837–840.
10. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugieres L, Jouannet P. Human ovarian tissue cryopreservation: Indications and feasibility. Hum Reprod. 2002. 17:1447–1452.
11. Gosden RG, Rutherford AJ, Norfolk DR. Transmission of malignant cells in ovarian grafts. Hum Reprod. 1997. 12:403.
12. Donnez J, Bassil S. Indications for cryopreservation of ovarian tissue. Hum Reprod Update. 1998. 4:248–259.
13. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000. 342:1919.
14. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005. 353:318–321.
15. Kim SS. Fertility preservation in female cancer patients: Current developments and future directions. Fertil Steril. 2006. 85:1–11.
16. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005. 83:1622–1628.
17. Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2004. 82:993–998.
18. Stachecki JJ, Cohen J. An overview of oocyte cryopreservation. Reprod Biomed Online. 2004. 9:152–163.
19. Borini A, Sciajno R, Bianchi V, Sereni E, Flamigni C, Coticchio G. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod. 2006. 21:512–517.
20. Levi Setti PE, Albani E, Novara PV, Cesana A, Morreale G. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod. 2006. 21:370–375.
21. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004. 364:1405–1410.
22. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: Successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist. 2007. 12:1437–1442.
23. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004. 10:251–266.
24. Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol. 2005. 17:299–308.
25. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003. 18:90–95.
26. Pfister CU, Martoni A, Zamagni C, Lelli G, De Braud F, Souppart C, et al. Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos. 2001. 22:191–197.
27. Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril. 2007. 88:657–664.
28. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006. 91:3885–3890.
29. Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986. 1:884–886.
30. Baka SG, Toth TL, Veeck LL, Jones HW Jr, Muasher SJ, Lanzendorf SE. Evaluation of the spindle apparatus of in-vitro matured human oocytes following cryopreservation. Hum Reprod. 1995. 10:1816–1820.
31. Borini A, Bonu MA, Coticchio G, Bianchi V, Cattoli M, Flamigni C. Pregnancies and births after oocyte cryopreservation. Fertil Steril. 2004. 82:601–605.
32. Porcu E. Oocyte freezing. Semin Reprod Med. 2001. 19:221–230.
33. Gook DA, Schiewe MC, Osborn SM, Asch RH, Jansen RP, Johnston WI. Intracytoplasmic sperm injection and embryo development of human oocytes cryopreserved using 1,2-propanediol. Hum Reprod. 1995. 10:2637–2641.
34. Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte cryopreservation: New perspectives regarding oocyte survival. Hum Reprod. 2001. 16:411–416.
35. Boldt J, Cline D, McLaughlin D. Human oocyte cryopreservation as an adjunct to IVF-embryo transfer cycles. Hum Reprod. 2003. 18:1250–1255.
36. Trad FS, Toner M, Biggers JD. Effects of cryoprotectants and ice-seeding temperature on intracellular freezing and survival of human oocytes. Hum Reprod. 1999. 14:1569–1577.
37. Eroglu A, Toner M, Toth TL. Beneficial effect of microinjected trehalose on the cryosurvival of human oocytes. Fertil Steril. 2002. 77:152–158.
38. Rall WF, Fahy GM. Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification. Nature. 1985. 313:573–575.
39. Trounson A. Preservation of human eggs and embryos. Fertil Steril. 1986. 46:1–12.
40. Yoon TK, Chung HM, Lim JM, Han SY, Ko JJ, Cha KY. Pregnancy and delivery of healthy infants developed from vitrified oocytes in a stimulated In vitro fertilization-embryo transfer program. Fertil Steril. 2000. 74:180–181.
41. Boiso I, Marti M, Santalo J, Ponsa M, Barri PN, Veiga A. A confocal microscopy analysis of the spindle and chromosome configurations of human oocytes cryopreserved at the germinal vesicle and metaphase II stage. Hum Reprod. 2002. 17:1885–1891.
42. Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv. 2007. 62:58–72.
43. Wu J, Zhang L, Wang X. In vitro maturation, fertilization and embryo development after ultrarapid freezing of immature human oocytes. Reproduction. 2001. 121:389–393.
44. Tucker MJ, Wright G, Morton PC, Massey JB. Birth after cryopreservation of immature oocytes with subsequent in vitro maturation. Fertil Steril. 1998. 70:578–579.
45. Tucker MJ, Morton PC, Wright G, Sweitzer CL, Massey JB. Clinical application of human egg cryopreservation. Hum Reprod. 1998. 13:3156–3159.
46. Practice Committee of the American Society for Reproductive Medicine . Practive Committee of the Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2006. 86:S142–S147.
47. Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod. 1994. 9:597–603.
48. Bordes A, Lornage J, Demirci B, Franck M, Courbiere B, Guerin JF, et al. Normal gestations and live births after orthotopic autograft of vitrified-warmed hemi-ovaries into ewes. Hum Reprod. 2005. 20:2745–2748.
49. Candy CJ, Wood MJ, Whittingham DG. Follicular development in cryopreserved marmoset ovarian tissue after transplantation. Hum Reprod. 1995. 10:2334–2338.
50. Salle B, Demirci B, Franck M, Rudigoz RC, Guerin JF, Lornage J. Normal pregnancies and live births after autograft of frozen-thawed hemi-ovaries into ewes. Fertil Steril. 2002. 77:403–408.
51. Almodin CG, Minguetti-Câmara VC, Meister H, Ferreira JO, Franco RL, Cavalcante AA, et al. Recovery of fertility after grafting of cryopreserved germinative tissue in female rabbits following radiotherapy. Hum Reprod. 2004. 19:1287–1293.
52. Lee DM, Yeoman RR, Battaglia DE, Stouffer RL, Zelinski-Wooten MB, Fanton JW, et al. Live birth after ovarian tissue transplant. Nature. 2004. 428:137–138.
53. Oktay K, Buyuk E, Rosenwaks Z, Rucinski J. A technique for transplantation of ovarian cortical strips to the forearm. Fertil Steril. 2003. 80:193–198.
54. Kim SS, Battaglia DE, Soules MR. The future of human ovarian cryopreservation and transplantation: fertility and beyond. Fertil Steril. 2001. 75:1049–1056.
55. Radford JA, Lieberman BA, Brison DR, Smith AR, Critchlow JD, Russell , et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet. 2001. 357:1172–1175.
56. Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001. 286:1490–1493.
57. Callejo J, Salvador C, Miralles A, Vilaseca S, Lailla JM, Balasch J. Long-term ovarian function evaluation after autografting by implantation with fresh and frozen-thawed human ovarian tissue. J Clin Endocrinol Metab. 2001. 86:4489–4494.
58. Kim SS, Hwang IT, Lee HC. Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function. Fertil Steril. 2004. 82:930–932.
59. Wølner-Hanssen P, Hägglund L, Ploman F, Ramirez A, Manthorpe R, Thuring A. Autotransplantation of cryopreserved ovarian tissue to the right forearm 4(1/2) years after autologous stem cell transplantation. Acta Obstet Gynecol Scand. 2005. 84:695–698.
60. Oktay K, Newton H, Mullan J, Gosden RG. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod. 1998. 13:1133–1138.
61. Gook DA, Edgar DH, Borg J, Archer J, Lutjen PJ, McBain JC. Oocyte maturation, follicle rupture and luteinization in human cryopreserved ovarian tissue following xenografting. Hum Reprod. 2003. 18:1772–1781.
62. Gook DA, Osborn SM, Archer J, Edgar DH, McBain J. Follicle development following cryopreservation of human ovarian tissue. Eur J Obstet Gynecol Reprod Biol. 2004. 113:Suppl 1. S60–S62.
63. Lucifero D, Mertineit C, Clarke HJ, Bestor TH, Trasler JM. Methylation dynamics of imprinted genes in mouse germ cells. Genomics. 2002. 79:530–538.
64. Martinez-Madrid B, Dolmans MM, Langendonckt AV, Defrère S, Van Eyck AS, Donnez J. Ficoll density gradient method for recovery of isolated human ovarian primordial follicles. Fertil Steril. 2004. 82:1648–1653.
65. Torrents E, Boiso I, Barri PN, Veiga A. Applications of ovarian tissue transplantation in experimental biology and medicine. Hum Reprod Update. 2003. 9:471–481.
66. Smitz JE, Cortvrindt RG. The earliest stages of folliculogenesis in vitro. Reproduction. 2002. 123:185–202.
67. Abir R, Fisch B, Nitke S, Okon E, Raz A, Ben Rafael Z. Morphological study of fully and partially isolated early human follicles. Fertil Steril. 2001. 75:141–146.
68. Laschke MW, Menger MD, Vollmar B. Ovariectomy improves neovascularization and microcirculation of freely transplanted ovarian follicles. J Endocrinol. 2002. 172:535–544.
69. Nisolle M, Casanas-Roux F, Qu J, Motta P, Donnez J. Histologic and ultrastructural evaluation of fresh and frozen-thawed human ovarian xenografts in nude mice. Fertil Steril. 2000. 74:122–129.
70. Liu J, Van der Elst J, Van den Broecke R, Dhont M. Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Hum Reprod. 2002. 17:605–611.
71. Wang X, Chen H, Yin H, Kim SS, Lin Tan S, Gosden RG. Fertility after intact ovary transplantation. Nature. 2002. 415:385.
72. Winston RM, Browne JC. Pregnancy following autograft transplantation of Fallopian tube and ovary in the rabbit. Lancet. 1974. 2:494–495.
73. Jeremias E, Bedaiwy MA, Gurunluoglu R, Biscotti CV, Siemionow M, Falcone T. Heterotopic autotransplantation of the ovary with microvascular anastomosis: A novel surgical technique. Fertil Steril. 2002. 77:1278–1282.
74. Paldi E, Gal D, Barzilai A, Hampel N, Malberger E. Genital organs. Auto and homotransplantation in forty dogs. Int J Fertil. 1975. 20:5–12.
75. Scott JR, Keye WR, Poulson AM, Reynolds WA. Microsurgical ovarian transplantation in the primate. Fertil Steril. 1981. 36:512–515.
76. Leporrier M, von Theobald P, Roffe JL, Muller G. A new technique to protect ovarian function before pelvic irradiation. Heterotopic ovarian autotransplantation. Cancer. 1987. 60:2201–2204.
77. Yin H, Wang X, Kim SS, Chen H, Tan SL, Gosden RG. Transplantation of intact rat gonads using vascular anastomosis: Effects of cryopreservation, ischaemia and genotype. Hum Reprod. 2003. 18:1165–1172.
78. Bedaiwy MA, Jeremias E, Gurunluoglu R, Hussein MR, Siemianow M, Biscotti C, et al. Restoration of ovarian function after autotransplantation of intact frozen-thawed sheep ovaries with microvascular anastomosis. Fertil Steril. 2003. 79:594–602.
79. Martinez-Madrid B, Dolmans MM, Van Langendonckt A, Defrere S, Donnez J. Freeze-thawing intact human ovary with its vascular pedicle with a passive cooling device. Fertil Steril. 2004. 82:1390–1394.
80. Bedaiwy MA, Hussein MR, Biscotti C, Falcone T. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod. 2006. 21:3258–3269.
81. Shaw JM, Bowles J, Koopman P, Wood EC, Trounson AO. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod. 1996. 11:1668–1673.
82. Shaw J, Trounson A. Oncological implications in the replacement of ovarian tissue. Hum Reprod. 1997. 12:403–405.
83. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008. 23:1007–1013.
84. Liede A, Narod SA. Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2. Hum Mutat. 2002. 20:413–424.
85. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002. 346:1609–1615.
86. Kim SS, Kang HG, Kim NH, Lee HC, Lee HH. Assessment of the integrity of human oocytes retrieved from cryopreserved ovarian tissue after xenotransplantation. Hum Reprod. 2005. 20:2502–2508.
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr